remdesivir
hydrogen peroxide
glycoprotein
penicillin
antiviral agent
chemical entity
albuterol
proline
azithromycin
bromhexine hydrochloride
lopinavir
pirfenidone
biomacromolecule
amino acid
protein
chloroquine
darunavir
clarithromycin
atazanavir
rosuvastatin
daunorubicin
ritonavir
paracetamol
dipyridamole
cefixime
erythromycin
mitoxantrone
pharmaceutical
atovaquone
hydroxychloroquine
ibuprofen
biomarker
cefditoren
ivermectin
metamizole
fingolimod
ribavirin
saquinavir
tipranavir
leflunomide
ruxolitinib
bepotastine
cobicistat
nelfinavir
tranilast
fosamprenavir
sofosbuvir
sulfonamide antibiotic
sildenafil
thalidomide
gravimetric sorption analysis
cryogenic electron microscopy
cell
cultured cell
mesenchymal stem cell
macrophage
cd4 - positive ,  alpha - beta t cell
cd8 - positive ,  alpha - beta t cell
leukocyte
memory b cell
mesenchymal stem cell of umbilical cord
covoc term
b - cell assays
confirmed case
conformational masking
fecal sample
glycan shielding
immunogenicity
intensive care
isolation
low - input metagenomic next - generation sequencing
major histocompatibility complex binding assays
nasopharyngeal sample
oropharyngeal sample
rapid testing
t - cell assays
t - cell epitopes
western - blot
possible case
probable case
nct04273321 clinical trial
nct04287686 angiotensin ii clinical trial
nct04288713 clinical trial
nct04292730 clinical trial
nct04292899 clinical trial
nct04295551 clinical trial
nct04304313 clinical trial
nct04306705 clinical trial
nct04307693 clinical trial
nct04307694 clinical trial
nct04310228 clinical trial
nct04315298 clinical trial
nct04315896 clinical trial
nct04291053 clinical trial
nct04321421 clinical trial
nct04306497 clinical trial
nct04317092 clinical trial
nct04318418 clinical trial
nct04321993 clinical trial
nct04304053 clinical trial
nct04313023 clinical trial
nct04323631 clinical trial
nct04312997 clinical trial
nct04315987 clinical trial
nct04273529 clinical trial
nct04273581 clinical trial
nct04280588 clinical trial
nct04293692 clinical trial
nct04317040 clinical trial
nct04288102 clinical trial
nct04286503 clinical trial
adaptive immune response
hypersensitivity
molecular_function
cellular_component
nucleolus
dna replication
dna recombination
translation
proteolysis
transport
autophagy
apoptotic process
immune response
biological_process
cell death
biosynthetic process
pathogenesis
tropism
gene expression
rna interference
phosphorylation
virion
viral nucleocapsid
viral release from host cell
viral genome replication
cell differentiation
viral membrane
viral dna genome replication
viral rna genome replication
growth
host cell
viral entry into host cell
membrane fusion
nucleic acid - templated transcription
region
country
hypertension
edema
skin rash
pruritus
urticaria
tachycardia
nasal obstruction
fever
vomiting
diarrhea
nausea and vomiting
nausea
abdominal pain
dyspnea
tachypnea
hyperlipidemia
myalgia
bronchiolitis
fatigue
pain
cough
chills
asthenia
crackles
nonproductive cough
rhinorrhea
abnormal sputum
diffuse alveolar damage
chest pain
sepsis
infectious agent transmissibility
infectivity
infectious disease pandemic
incubation period
serology test
gene therapy
depressive disorder
pharyngitis
anemia  ( disease )
asthma
cardiovascular disease
chronic obstructive pulmonary disease
diabetes mellitus  ( disease )
severe acute respiratory syndrome
viral infectious disease
pneumonia
infectious disease
anxiety disorder
coronavinae infectious disease
influenza
acute respiratory distress syndrome
gastroesophageal reflux disease
headache disorder
viral respiratory tract infection
respiratory tract infectious disease
zoonosis
anaphylaxis
covid - 19
middle east respiratory syndrome
vector - borne disease
asymptomatic covid - 19 infection
mild covid - 19 infection
moderate covid - 19 infection
severe covid - 19 infection
critical covid - 19 infection
triage status
next generation sequencing
ace2 gene
distribution
amino acid sequence
epitope
bronchoalveolar lavage fluid
open reading frame
dna sequence
serum
tlr 2 / 6 / 9 agonist pul - 042
rna recognition motif
macromolecular structure
clinical study
diagnosis
immunization
study design
database
research activity
nasopharyngeal swab specimen
surveillance
clinical data
preventive intervention
vaccine design
epidemiology
gene
microbiology
mathematical model
morbidity
patient
physiology
prevalence
public health
research personnel
rna - directed rna polymerase
survival
disease transmission
genetic variation
guideline
sequence analysis
immunologic tolerance
blocking antibody
histopathologic examination
single nucleotide polymorphism
protein - protein interaction
rna analysis
medical occupation
permissiveness
monoclonal antibody
cytokine
interferon
drug tolerance
tmprss2 gene
hospitalization
sensitivity
therapeutic
identifier
analysis
vaccine research
protective agent
chest radiography
asymptomatic
diagnostic specificity
medication
cell count
adenovirus vaccine
health care professional
travel
spread
emergency
contamination
purification
mechanical ventilation
clinical trial
quarantine
world health organization
clinical significance
rna sequence
vaccine
neutralization
planned process
assay
population
reverse transcribed polymerase chain reaction
enzyme - linked immunosorbent assay
organism
specimen
quality
biological sex
occurrence
viability
male
dead
dipeptidyl peptidase iv
interleukin - 10
furin
angiotensinogen ,  signal peptide removed form
igg heavy chain protein
non - structural protein 3  ( sars - cov - 2 )
transmembrane protease serine 2  ( human )
replicase polyprotein 1a  ( sars - cov - 2 )
spike glycoprotein  ( sars - cov - 2 )
orf3a protein  ( sars - cov - 2 )
envelope small membrane protein  ( sars - cov - 2 )
membrane protein  ( sars - cov - 2 )
orf7a protein  ( sars - cov - 2 )
nucleoprotein  ( sars - cov - 2 )
replicase polyprotein 1ab  ( sars - cov - 2 )
angiotensin - converting enzyme  ( human )
interleukin - 10  ( human )
angiotensin - converting enzyme 2  ( human )
c - type lectin domain family 4 member m  ( human )
anatomical entity
urine
saliva
feces
lung
experimental factor
antibody
disease
genetic modification
host
infection
overall survival
pathogen
phenotype
respiratory system disease
survival time
survival probability
transfection
treatment
control
medical procedure
sign or symptom
risk factor
vaccination
mortality
genome
age at onset
huh - 7
clinical treatment
croup
malaise
wheezing
shortness of breath
therapeutic procedure
pharmacotherapy
viral load
primer
coinfection
afebrile
